Drug Shortage Report for TEVA-SALBUTAMOL STERINEBS P.F.
Report ID | 215707 |
Drug Identification Number | 01926934 |
Brand name | TEVA-SALBUTAMOL STERINEBS P.F. |
Common or Proper name | SALBUTAMOL 1MG/ML NEBS |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | SALBUTAMOL |
Strength(s) | 1MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 20 X 2.5ML |
ATC code | R03AC |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-10 |
Estimated end date | 2024-11-30 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-04-18 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-04-18 | French | Compare |
v7 | 2024-04-18 | English | Compare |
v6 | 2024-02-15 | French | Compare |
v5 | 2024-02-15 | English | Compare |
v4 | 2024-01-18 | French | Compare |
v3 | 2024-01-18 | English | Compare |
v2 | 2024-01-11 | French | Compare |
v1 | 2024-01-11 | English | Compare |
Showing 1 to 8 of 8